Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Net Income towards Common Stockholders: 2012-2025

Historic Net Income towards Common Stockholders for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $19.1 million.

  • Veracyte's Net Income towards Common Stockholders rose 26.33% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 426.92%. This contributed to the annual value of $24.1 million for FY2024, which is 132.44% up from last year.
  • Latest data reveals that Veracyte reported Net Income towards Common Stockholders of $19.1 million as of Q3 2025, which was up 2,052.76% from -$980,000 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Net Income towards Common Stockholders registered a high of $19.1 million during Q3 2025, and its lowest value of -$41.9 million during Q1 2021.
  • For the 3-year period, Veracyte's Net Income towards Common Stockholders averaged around -$2.3 million, with its median value being -$980,000 (2025).
  • In the last 5 years, Veracyte's Net Income towards Common Stockholders crashed by 630.33% in 2023 and then surged by 477.04% in 2025.
  • Quarterly analysis of 5 years shows Veracyte's Net Income towards Common Stockholders stood at -$10.5 million in 2021, then surged by 63.16% to -$3.9 million in 2022, then tumbled by 630.33% to -$28.3 million in 2023, then skyrocketed by 118.16% to $5.1 million in 2024, then rose by 26.33% to $19.1 million in 2025.
  • Its last three reported values are $19.1 million in Q3 2025, -$980,000 for Q2 2025, and $7.0 million during Q1 2025.